ArticleTherapeutic advances in infectious disease

Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).

Kazuko Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.